公司资料
Biodexa Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- BDRX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United Kingdom and listed in the U
股票表现
0.68 USD (-6.86%)
收盘价
最后更新: 2026年9月21日
2.61M USD
市值
股价为何变动
截至 2026年9月21日，BDRX 下跌 6.86%，收于 $0.6799。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Biodexa Pharmaceuticals is a specialty pharmaceutical company focused on oncology and rare disease. Its story is built around using focused development programs to address high-unmet-need conditions.
所在地与行业分类
Biodexa is headquartered in the United Kingdom and listed in the U.S. market. It sits in specialty pharma and oncology development.
商业模式特征
The company depends on clinical progress, capital efficiency, and the ability to maintain a narrow pipeline. Investors usually watch data updates and strategic changes.
生物医药行业定位
Biodexa occupies a small oncology/rare-disease niche within biotech-adjacent pharma. It is a catalyst-driven story where a limited number of programs dominate the valuation.
未来催化剂
- Biodexa’s catalysts are its oncology and rare-disease programs, plus any strategic update that clarifies the company’s next move. The stock remains highly dependent on clinical proof.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。